Courier is a data-driven platform for developing highly targeted cancer therapies. The company was acquired by Valo Health in 2021 which subsequently went public in 2021 through an acquisition by Khosla Ventures Acquisition Corp.
Courier is a data-driven platform for developing highly targeted cancer therapies. The company was acquired by Valo Health in 2021 which subsequently went public in 2021 through an acquisition by Khosla Ventures Acquisition Corp.
